应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
ABBV 艾伯维公司
交易中 10-31 11:54:36 EDT
218.28
-9.92
-4.35%
最高
223.59
最低
216.00
成交量
352.30万
今开
222.98
昨收
228.20
日振幅
3.33%
总市值
3,856亿
流通市值
3,848亿
总股本
17.67亿
成交额
7.71亿
换手率
0.20%
流通股本
17.63亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
艾伯维公司高管表示，预计2025年Skyrizi全球销售总额为173亿美元，比之前的预测增加2亿美元
美股速递 · 13:33
艾伯维公司高管表示，预计2025年Skyrizi全球销售总额为173亿美元，比之前的预测增加2亿美元
艾伯维公司高管表示预计2025年净收入将达到约609亿美元，比此前预期增加4亿美元
美股速递 · 13:31
艾伯维公司高管表示预计2025年净收入将达到约609亿美元，比此前预期增加4亿美元
艾伯维公司高管表示，预计今年及2026年赫努拉(Humira)销量侵蚀加剧，但部分受益于价格提振
美股速递 · 13:18
艾伯维公司高管表示，预计今年及2026年赫努拉(Humira)销量侵蚀加剧，但部分受益于价格提振
Elahere®获得加拿大药品管理局针对特定类型铂耐药卵巢癌的积极报销推荐
美股速递 · 10-30 11:03
Elahere®获得加拿大药品管理局针对特定类型铂耐药卵巢癌的积极报销推荐
艾伯维公司公布评估Upadacitinib（Rinvoq®）治疗成人和青少年白癜风的三期关键研究的积极初步结果
美股速递 · 10-29 12:12
艾伯维公司公布评估Upadacitinib（Rinvoq®）治疗成人和青少年白癜风的三期关键研究的积极初步结果
艾伯维公司与Girls Inc.及Skinspirit合作，激励未来女性STEM领导者
美股速递 · 10-28
艾伯维公司与Girls Inc.及Skinspirit合作，激励未来女性STEM领导者
Rinvoq® (Upadacitinib) 在类风湿性关节炎患者中显示出比 Humira® (Adalimumab) 在主要终点上的优越性
美股速递 · 10-20
Rinvoq® (Upadacitinib) 在类风湿性关节炎患者中显示出比 Humira® (Adalimumab) 在主要终点上的优越性
艾伯维(ABBV.US)1类新药国内报上市
智通财经 · 10-14
艾伯维(ABBV.US)1类新药国内报上市
美国食品药品监督管理局(FDA)批准Rinvoq®(乌帕替尼)治疗炎症性肠病的更新适应症声明
美股速递 · 10-13
美国食品药品监督管理局(FDA)批准Rinvoq®(乌帕替尼)治疗炎症性肠病的更新适应症声明
艾伯维公司公布第二期Elate临床试验积极的主要结果，评估Onabotulinumtoxina（Botox®）治疗上肢特发性震颤
美股速递 · 10-06
艾伯维公司公布第二期Elate临床试验积极的主要结果，评估Onabotulinumtoxina（Botox®）治疗上肢特发性震颤
艾伯维公司：Onabotulinumtoxina安全性结果与其已确立的安全特征保持一致
美股速递 · 10-06
艾伯维公司：Onabotulinumtoxina安全性结果与其已确立的安全特征保持一致
艾伯维公司2025年全年调整后每股收益预期范围（含知识产权研发影响）为10.38-10.58美元
美股速递 · 10-03
艾伯维公司2025年全年调整后每股收益预期范围（含知识产权研发影响）为10.38-10.58美元
艾伯维公司启动7000万美元扩建项目 进一步增强美国生物制药制造和研发实力
美股速递 · 09-30
艾伯维公司启动7000万美元扩建项目 进一步增强美国生物制药制造和研发实力
AbbVie向美国FDA提交Pivekimab Sunirine (PVEK)生物制品许可申请 - 用于治疗治疗选择有限的罕见癌症的研究性抗体药物偶联物(ADC)
美股速递 · 09-30
AbbVie向美国FDA提交Pivekimab Sunirine (PVEK)生物制品许可申请 - 用于治疗治疗选择有限的罕见癌症的研究性抗体药物偶联物(ADC)
艾伯维公司向美国FDA提交Tavapadon新药申请，用于治疗帕金森病
美股速递 · 09-26
艾伯维公司向美国FDA提交Tavapadon新药申请，用于治疗帕金森病
Qulipta®（阿托司潘）现已在魁北克省获得慢性偏头痛公共报销，CGRP类药物审查已发布
美股速递 · 09-25
Qulipta®（阿托司潘）现已在魁北克省获得慢性偏头痛公共报销，CGRP类药物审查已发布
艾伯维(ABBV.US)旗下艾可瑞妥单抗在华申报新适应症
智通财经 · 09-24
艾伯维(ABBV.US)旗下艾可瑞妥单抗在华申报新适应症
Allergan Aesthetics宣布将Skinvive by JuvÉDerm®扩展至35个新市场，进一步推进全球肌肤品质提升承诺
美股速递 · 09-23
Allergan Aesthetics宣布将Skinvive by JuvÉDerm®扩展至35个新市场，进一步推进全球肌肤品质提升承诺
艾伯维(ABBV.US)与仿制药企业就核心免疫药物Rinvoq达成和解
智通财经 · 09-12
艾伯维(ABBV.US)与仿制药企业就核心免疫药物Rinvoq达成和解
美股周四尾盘艾伯维(AbbVie,ABBV)股价上涨4.21%创该公司2012年从雅培实验室(ABT)拆分独立上市以来的
智通财经 · 09-11
美股周四尾盘艾伯维(AbbVie,ABBV)股价上涨4.21%创该公司2012年从雅培实验室(ABT)拆分独立上市以来的
加载更多
公司概况
公司名称：
艾伯维公司
所属市场：
NYSE
上市日期：
--
主营业务：
艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。
发行价格：
--
{"stockData":{"symbol":"ABBV","market":"US","secType":"STK","nameCN":"艾伯维公司","latestPrice":218.275,"timestamp":1761926076480,"preClose":228.2,"halted":0,"volume":3522958,"delay":0,"floatShares":1762950764,"shares":1766558253,"eps":2.100163,"marketStatus":"交易中","change":-9.925,"latestTime":"10-31 11:54:36 EDT","open":222.98,"high":223.59,"low":216,"amount":770831242.74424,"amplitude":0.03326,"askPrice":218.38,"askSize":116,"bidPrice":218.17,"bidSize":241,"shortable":3,"etf":0,"ttmEps":2.100163,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1761940800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":228.2,"dividendRate":0.029642,"preHourTrading":{"tag":"盘前","latestPrice":222.99,"preClose":228.2,"latestTime":"09:29 EDT","volume":56435,"amount":12703113.296699999,"timestamp":1761917399784},"postHourTrading":{"tag":"盘后","latestPrice":227,"preClose":228.2,"latestTime":"19:59 EDT","volume":417657,"amount":95225603.932,"timestamp":1761868789227},"volumeRatio":2.305079,"optionData":{"bulkOrders":[{"symbol":"ABBV","call":false,"expireDate":1761883200000,"strike":"217.5","timestamp":1761918648759,"price":1.8,"volume":1650,"amount":297000,"type":"-"}]},"impliedVol":0.2422,"impliedVolPercentile":0.268},"requestUrl":"/m/hq/s/abbv","defaultTab":"news","newsList":[{"id":"1169764688","title":"艾伯维公司高管表示，预计2025年Skyrizi全球销售总额为173亿美元，比之前的预测增加2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169764688","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169764688?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:33","pubTimestamp":1761917604,"startTime":"0","endTime":"0","summary":"艾伯维公司高管表示，预计2025年Skyrizi全球销售总额为173亿美元，比之前的预测增加2亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732800096.USD","LU1244550494.USD","LU1057294990.SGD","LU1496350171.SGD","LU0203347892.USD","LU0661504455.SGD","LU1093756168.USD","SG9999011175.SGD","IE00BVYPNW00.USD","LU1074936037.SGD","LU1244550577.SGD","LU1496350502.SGD","BK4139","LU0211327993.USD","LU1023059063.AUD","LU2237443549.SGD","LU2089283258.USD","BK4585","LU0949170772.SGD","ABBV","IE00B4R5TH58.HKD","LU1934455277.USD","BK4533","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1718418525.SGD","LU1989771016.USD","LU1929549753.HKD","IE00BJT1NW94.SGD","LU0985320562.USD","LU0795875086.SGD","IE0002141913.USD","LU1551013342.USD","SG9999003800.SGD","IE0002270589.USD","LU1162221912.USD","LU0820561818.USD","LU2089984988.USD","LU1989772840.SGD","SG9999015978.USD","LU0256863902.USD","LU2112291526.USD","LU0211328371.USD","LU0456855351.SGD","IE00B19Z3B42.SGD","LU1934455194.USD","IE00BVYPNV92.GBP","LU0912757837.SGD","LU0689626769.HKD","IE00B19Z3581.USD","LU1003077747.HKD","LU1093756325.SGD","LU2237443978.SGD","LU2237443895.HKD","SG9999015945.SGD","IE00BGHQF631.EUR","LU0320765646.SGD","LU2468319806.SGD","BK4534","SG9999015952.SGD","LU2129689431.USD","IE00BFTCPJ56.SGD","LU0708994859.HKD","LU0158827948.USD","IE00B42XCP33.USD","LU0795875169.SGD","LU0029864427.USD","LU0170899867.USD","LU1061106388.HKD","LU2023251221.USD","LU0203345920.USD","LU1244550221.USD","BK4566","LU2087621335.USD","LU0058720904.USD","IE00BBT3K403.USD","LU1934455863.HKD","LU0861579265.USD","IE00BN8TJ469.HKD","LU0432979614.USD","LU0234572021.USD","LU0820561909.HKD","LU0545039389.USD","LU1037948541.HKD","LU1267930490.SGD","LU2347655156.SGD","LU0310800379.SGD","LU0882574055.USD","IE00BLSP4452.SGD","LU0738911758.USD","LU2129689605.HKD","LU0198837287.USD","LU0256863811.USD","LU0122379950.USD","LU0114720955.EUR","LU0965509283.SGD","LU0965508806.USD","BK4559","LU0417517546.SGD","LU1585245621.USD","LU0965509010.AUD","LU1989772923.USD","LU2237443465.HKD","IE00B3PB1722.GBP","BK4550","IE0004445239.USD","LU0289739699.SGD","BK4581","IE0009355771.USD","LU1732799900.SGD","LU0553294199.USD","LU1291159041.SGD","BK4588","SG9999015986.USD","LU2237443382.USD","LU2089284900.SGD","LU0310799852.SGD","LU0234570918.USD","IE00BSNM7G36.USD","SG9999001440.SGD","LU0965509101.SGD","LU2237443622.USD","LU1839511570.USD","LU0943347566.SGD","LU2129689514.USD","IE00BDGV0183.EUR","LU1430594728.SGD","LU1037948897.HKD","LU2133065610.SGD","LU0124676726.USD","LU0689472784.USD","LU1267930573.SGD","LU1983299246.USD","LU1551013425.SGD","LU0128525929.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"1150959988","title":"艾伯维公司高管表示预计2025年净收入将达到约609亿美元，比此前预期增加4亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150959988","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150959988?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:31","pubTimestamp":1761917474,"startTime":"0","endTime":"0","summary":"艾伯维公司高管表示预计2025年净收入将达到约609亿美元，比此前预期增加4亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3PB1722.GBP","LU2129689431.USD","IE0002270589.USD","LU1074936037.SGD","LU1718418525.SGD","LU1929549753.HKD","IE00B42XCP33.USD","IE0004445239.USD","LU1934455863.HKD","LU2089284900.SGD","LU1934455277.USD","IE00BVYPNW00.USD","LU0417517546.SGD","IE00BDGV0183.EUR","LU2237443622.USD","LU2129689605.HKD","LU1989771016.USD","LU0985320562.USD","LU0198837287.USD","LU0128525929.USD","LU2133065610.SGD","LU0882574055.USD","LU0211328371.USD","SG9999015952.SGD","ABBV","LU0158827948.USD","LU1585245621.USD","LU0912757837.SGD","LU0234572021.USD","BK4559","LU0708994859.HKD","LU0738911758.USD","LU0310800379.SGD","LU1037948897.HKD","LU1496350171.SGD","LU0965508806.USD","LU1934455194.USD","LU0203347892.USD","LU2237443465.HKD","LU2237443895.HKD","LU1093756325.SGD","LU0211327993.USD","LU1037948541.HKD","LU2237443978.SGD","IE00BFTCPJ56.SGD","LU2237443549.SGD","LU1430594728.SGD","LU1093756168.USD","LU0289739699.SGD","LU1732800096.USD","LU0943347566.SGD","LU0456855351.SGD","LU0965509010.AUD","IE0002141913.USD","IE00BGHQF631.EUR","IE00BN8TJ469.HKD","LU0965509101.SGD","LU1551013425.SGD","SG9999003800.SGD","BK4534","IE00B19Z3B42.SGD","LU2089283258.USD","LU2347655156.SGD","LU0256863902.USD","IE00BJJMRZ35.SGD","SG9999001440.SGD","BK4588","LU0124676726.USD","LU1267930573.SGD","LU0965509283.SGD","IE00BLSP4452.SGD","LU0122379950.USD","IE00BVYPNV92.GBP","LU1244550221.USD","LU0820561909.HKD","LU1023059063.AUD","LU2023251221.USD","LU1057294990.SGD","LU1267930490.SGD","LU2468319806.SGD","LU0170899867.USD","LU0234570918.USD","LU2112291526.USD","LU2087621335.USD","SG9999015986.USD","LU0029864427.USD","LU0689626769.HKD","IE00B19Z3581.USD","IE00B2B36J28.USD","LU1839511570.USD","LU0795875086.SGD","LU1496350502.SGD","SG9999011175.SGD","LU1003077747.HKD","LU0114720955.EUR","IE00BSNM7G36.USD","LU0661504455.SGD","BK4581","BK4139","LU1983299246.USD","LU0949170772.SGD","LU0820561818.USD","LU0861579265.USD","LU0203345920.USD","LU0310799852.SGD","LU1551013342.USD","BK4585","SG9999015978.USD","LU0320765646.SGD","IE00B4R5TH58.HKD","LU1732799900.SGD","LU0689472784.USD","IE00BLSP4239.USD","BK4566","LU0432979614.USD","LU0256863811.USD","LU1061106388.HKD","LU1244550494.USD","SG9999015945.SGD","LU0795875169.SGD","LU2129689514.USD","LU0553294199.USD","LU1244550577.SGD","BK4533","LU1162221912.USD","LU1291159041.SGD","IE00BJT1NW94.SGD","BK4550","IE00BBT3K403.USD","LU0058720904.USD","LU1989772923.USD","LU2237443382.USD","LU2089984988.USD","LU0545039389.USD","IE0009355771.USD","LU1989772840.SGD"],"gpt_icon":0},{"id":"1172689202","title":"艾伯维公司高管表示，预计今年及2026年赫努拉(Humira)销量侵蚀加剧，但部分受益于价格提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1172689202","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172689202?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:18","pubTimestamp":1761916724,"startTime":"0","endTime":"0","summary":"艾伯维公司高管表示，预计今年及2026年赫努拉(Humira)销量侵蚀加剧，但部分受益于价格提振","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","BK4585","IE00B19Z3B42.SGD","LU0289739699.SGD","LU2347655156.SGD","IE0002141913.USD","ABBV","LU1162221912.USD","LU0861579265.USD","LU2237443382.USD","LU2237443549.SGD","LU0211328371.USD","LU1934455863.HKD","LU0256863902.USD","LU1244550577.SGD","LU0310800379.SGD","LU1023059063.AUD","LU2129689514.USD","LU0553294199.USD","IE00BJT1NW94.SGD","LU0965509101.SGD","BK4534","LU0114720955.EUR","LU1003077747.HKD","LU1430594728.SGD","IE00BGHQF631.EUR","LU1929549753.HKD","SG9999003800.SGD","LU0029864427.USD","LU0198837287.USD","LU0661504455.SGD","LU0985320562.USD","BK4139","SG9999015945.SGD","LU2089284900.SGD","LU1496350171.SGD","LU1718418525.SGD","LU0124676726.USD","LU0949170772.SGD","LU2089283258.USD","IE00BN8TJ469.HKD","LU0432979614.USD","SG9999015978.USD","LU0417517546.SGD","LU0882574055.USD","LU1585245621.USD","IE00BLSP4239.USD","IE00BSNM7G36.USD","LU0128525929.USD","LU0211327993.USD","LU1291159041.SGD","SG9999011175.SGD","IE00BVYPNV92.GBP","LU0820561909.HKD","LU1496350502.SGD","LU0795875086.SGD","BK4588","LU2237443895.HKD","LU0708994859.HKD","LU1989771016.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU1839511570.USD","BK4566","LU1989772840.SGD","LU2237443978.SGD","LU1037948897.HKD","LU2468319806.SGD","IE00B42XCP33.USD","LU2112291526.USD","LU2087621335.USD","LU0320765646.SGD","IE00BLSP4452.SGD","IE00B2B36J28.USD","LU2023251221.USD","LU1551013425.SGD","LU2237443622.USD","LU0234572021.USD","LU1057294990.SGD","IE00B3PB1722.GBP","LU0820561818.USD","LU2237443465.HKD","LU1244550494.USD","LU0912757837.SGD","LU0795875169.SGD","LU0234570918.USD","LU1934455277.USD","LU1267930490.SGD","BK4559","LU0170899867.USD","LU2129689605.HKD","SG9999015986.USD","LU0122379950.USD","LU0203347892.USD","LU1093756168.USD","LU2129689431.USD","LU0965508806.USD","SG9999015952.SGD","LU0058720904.USD","IE00BDGV0183.EUR","LU0738911758.USD","LU0203345920.USD","BK4550","LU0943347566.SGD","LU0965509283.SGD","LU1093756325.SGD","LU1074936037.SGD","LU1267930573.SGD","LU0689626769.HKD","IE0004445239.USD","LU1989772923.USD","IE00BFTCPJ56.SGD","LU1037948541.HKD","SG9999001440.SGD","IE0002270589.USD","LU1732800096.USD","LU1983299246.USD","LU2089984988.USD","LU2133065610.SGD","BK4581","LU0310799852.SGD","LU1244550221.USD","LU0256863811.USD","IE0009355771.USD","IE00BBT3K403.USD","LU1732799900.SGD","LU0689472784.USD","BK4533","IE00B4R5TH58.HKD","LU1934455194.USD","LU0158827948.USD","LU0965509010.AUD","LU0545039389.USD","IE00BVYPNW00.USD","LU1551013342.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"1151566134","title":"Elahere®获得加拿大药品管理局针对特定类型铂耐药卵巢癌的积极报销推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=1151566134","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151566134?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:03","pubTimestamp":1761822195,"startTime":"0","endTime":"0","summary":"Elahere®获得加拿大药品管理局针对特定类型铂耐药卵巢癌的积极报销推荐","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BN8TJ469.HKD","LU0158827948.USD","BK4566","LU1732799900.SGD","IE00BGHQF631.EUR","LU0234570918.USD","IE00B3PB1722.GBP","LU0738911758.USD","IE00B2B36J28.USD","SG9999015986.USD","LU0310799852.SGD","LU1267930573.SGD","LU1093756325.SGD","IE0009355771.USD","LU0689472784.USD","LU0882574055.USD","SG9999015952.SGD","LU0211328371.USD","LU1989772923.USD","LU2129689605.HKD","LU2237443895.HKD","LU0861579265.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","SG9999015945.SGD","LU2468319806.SGD","LU0114720955.EUR","LU1061106388.HKD","ABBV","IE00BSNM7G36.USD","LU0456855351.SGD","LU2347655156.SGD","LU0289739699.SGD","LU2089984988.USD","IE00B42XCP33.USD","LU1037948541.HKD","LU2237443382.USD","LU2087621335.USD","LU0310800379.SGD","LU0985320562.USD","SG9999015978.USD","LU0689626769.HKD","LU0553294199.USD","LU1074936037.SGD","LU1244550221.USD","LU1934455277.USD","LU1057294990.SGD","LU1551013342.USD","SG9999001440.SGD","LU0128525929.USD","LU2089283258.USD","LU0912757837.SGD","LU1934455194.USD","LU1162221912.USD","LU0795875086.SGD","LU1934455863.HKD","IE0004445239.USD","LU0795875169.SGD","LU0965509101.SGD","LU2112291526.USD","LU1244550494.USD","IE00BLSP4239.USD","IE00BDGV0183.EUR","LU2129689431.USD","BK4534","LU0234572021.USD","IE0002141913.USD","LU0122379950.USD","LU0211327993.USD","LU1718418525.SGD","LU1244550577.SGD","LU2129689514.USD","IE00BLSP4452.SGD","LU0256863811.USD","LU1496350171.SGD","LU0965509283.SGD","IE00B4R5TH58.HKD","LU0417517546.SGD","LU1585245621.USD","LU0256863902.USD","LU1291159041.SGD","LU1430594728.SGD","LU1989771016.USD","BK4533","LU1551013425.SGD","LU2237443978.SGD","IE0002270589.USD","LU0432979614.USD","LU1037948897.HKD","BK4559","BK4139","LU1929549753.HKD","IE00B19Z3B42.SGD","IE00BVYPNW00.USD","LU0029864427.USD","LU0820561909.HKD","LU2237443622.USD","LU2023251221.USD","LU0820561818.USD","LU1093756168.USD","LU0124676726.USD","IE00BVYPNV92.GBP","LU2133065610.SGD","LU0545039389.USD","LU1023059063.AUD","SG9999003800.SGD","LU0320765646.SGD","LU1983299246.USD","LU2237443465.HKD","BK4588","LU0198837287.USD","SG9999011175.SGD","LU1003077747.HKD","LU1496350502.SGD","LU1732800096.USD","LU0943347566.SGD","BK4550","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0965509010.AUD","LU0949170772.SGD","BK4581","LU2089284900.SGD","LU0203347892.USD","LU1839511570.USD","IE00BFTCPJ56.SGD","LU0203345920.USD","LU0708994859.HKD","LU1989772840.SGD","LU0661504455.SGD","LU0170899867.USD","LU1267930490.SGD","IE00BJT1NW94.SGD","LU0965508806.USD","LU2237443549.SGD"],"gpt_icon":0},{"id":"1122193491","title":"艾伯维公司公布评估Upadacitinib（Rinvoq®）治疗成人和青少年白癜风的三期关键研究的积极初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1122193491","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122193491?lang=zh_cn&edition=full","pubTime":"2025-10-29 20:12","pubTimestamp":1761739938,"startTime":"0","endTime":"0","summary":"艾伯维公司公布评估Upadacitinib（Rinvoq®）治疗成人和青少年白癜风的三期关键研究的积极初步结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0545039389.USD","LU1291159041.SGD","LU0203347892.USD","BK4533","LU0820561909.HKD","LU2237443978.SGD","LU2133065610.SGD","LU0234570918.USD","BK4566","IE00BLSP4239.USD","LU1551013425.SGD","BK4559","BK4581","LU0661504455.SGD","LU0456855351.SGD","LU1839511570.USD","LU1983299246.USD","IE00B19Z3B42.SGD","LU2468319806.SGD","LU1162221912.USD","LU2023251221.USD","BK4585","IE00BGHQF631.EUR","LU1037948897.HKD","LU1496350171.SGD","LU2237443549.SGD","LU1718418525.SGD","LU0861579265.USD","IE00B2B36J28.USD","LU1989772840.SGD","IE00B3PB1722.GBP","BK4139","LU0128525929.USD","LU0882574055.USD","LU1267930490.SGD","LU0965509101.SGD","LU1023059063.AUD","SG9999001440.SGD","LU1585245621.USD","LU0058720904.USD","LU2237443895.HKD","LU1037948541.HKD","LU2089284900.SGD","LU1551013342.USD","IE0002141913.USD","LU0985320562.USD","IE00B19Z3581.USD","BK4534","LU0029864427.USD","LU0158827948.USD","LU0795875169.SGD","LU0689626769.HKD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","LU2237443622.USD","LU0211328371.USD","LU1430594728.SGD","LU2129689514.USD","LU0211327993.USD","IE00BJJMRZ35.SGD","LU2237443382.USD","LU0553294199.USD","LU0820561818.USD","LU1989771016.USD","IE0004445239.USD","LU0912757837.SGD","LU0943347566.SGD","LU0965509283.SGD","LU0795875086.SGD","ABBV","LU0310800379.SGD","BK4550","SG9999015952.SGD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU1929549753.HKD","IE00B42XCP33.USD","LU0432979614.USD","LU1244550577.SGD","LU2129689431.USD","SG9999015986.USD","LU1989772923.USD","LU0124676726.USD","LU1934455277.USD","LU1496350502.SGD","LU0965509010.AUD","LU2347655156.SGD","LU0320765646.SGD","LU1934455194.USD","LU0949170772.SGD","LU2089984988.USD","LU0234572021.USD","LU1244550221.USD","IE00BSNM7G36.USD","SG9999011175.SGD","SG9999003800.SGD","IE0002270589.USD","IE00BVYPNW00.USD","IE0009355771.USD","LU1061106388.HKD","LU1003077747.HKD","LU1057294990.SGD","LU2089283258.USD","LU0289739699.SGD","IE00BDGV0183.EUR","LU0203345920.USD","BK4588","LU0198837287.USD","LU2112291526.USD","LU1732799900.SGD","LU2129689605.HKD","LU0965508806.USD","LU0708994859.HKD","LU0689472784.USD","LU0122379950.USD","LU1934455863.HKD","LU1732800096.USD","IE00BVYPNV92.GBP","IE00BBT3K403.USD","SG9999015945.SGD","LU1093756325.SGD","LU1074936037.SGD","LU1244550494.USD","LU0114720955.EUR","LU2087621335.USD","LU0310799852.SGD","LU0256863902.USD","LU0417517546.SGD","LU0170899867.USD","LU0738911758.USD","LU0256863811.USD","SG9999015978.USD","LU1093756168.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"1182860083","title":"艾伯维公司与Girls Inc.及Skinspirit合作，激励未来女性STEM领导者","url":"https://stock-news.laohu8.com/highlight/detail?id=1182860083","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182860083?lang=zh_cn&edition=full","pubTime":"2025-10-28 21:01","pubTimestamp":1761656479,"startTime":"0","endTime":"0","summary":"艾伯维公司与Girls Inc.及Skinspirit合作，激励未来女性STEM领导者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","LU1267930573.SGD","LU2468319806.SGD","LU1037948897.HKD","LU0256863902.USD","IE00B19Z3581.USD","LU0795875169.SGD","LU0211328371.USD","LU1551013425.SGD","LU1934455863.HKD","LU0949170772.SGD","LU1093756325.SGD","LU0689472784.USD","LU1023059063.AUD","LU0689626769.HKD","BK4534","BK4581","LU0708994859.HKD","LU1003077747.HKD","IE00BFTCPJ56.SGD","LU0985320562.USD","LU2237443465.HKD","LU1093756168.USD","LU1244550577.SGD","LU0943347566.SGD","LU1551013342.USD","IE00B2B36J28.USD","LU2129689514.USD","LU0158827948.USD","LU0795875086.SGD","IE0002141913.USD","IE00B3PB1722.GBP","LU1934455194.USD","LU0861579265.USD","LU0882574055.USD","LU1983299246.USD","LU0234572021.USD","LU1732799900.SGD","LU2237443895.HKD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU2237443622.USD","IE00BBT3K403.USD","ABBV","LU0965509101.SGD","SG9999015952.SGD","LU2347655156.SGD","LU0124676726.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU2237443978.SGD","LU2129689605.HKD","LU0170899867.USD","LU1074936037.SGD","BK4566","LU1929549753.HKD","LU1989772840.SGD","LU0965509283.SGD","IE00BVYPNV92.GBP","SG9999015945.SGD","IE00BVYPNW00.USD","BK4585","LU0820561818.USD","LU1496350171.SGD","IE0002270589.USD","LU0234570918.USD","LU2089284900.SGD","IE00BSNM7G36.USD","LU2023251221.USD","LU0545039389.USD","LU1989772923.USD","LU1061106388.HKD","LU0820561909.HKD","IE0004445239.USD","LU1267930490.SGD","LU2112291526.USD","LU1162221912.USD","LU2087621335.USD","IE00B42XCP33.USD","LU0320765646.SGD","LU2237443382.USD","BK4533","LU0203345920.USD","LU0661504455.SGD","IE0009355771.USD","LU0203347892.USD","LU0738911758.USD","LU0965508806.USD","LU1291159041.SGD","LU0256863811.USD","LU1839511570.USD","LU1037948541.HKD","LU0289739699.SGD","LU2237443549.SGD","LU1732800096.USD","LU1244550221.USD","LU1430594728.SGD","LU0114720955.EUR","LU1496350502.SGD","SG9999015986.USD","SG9999015978.USD","LU0456855351.SGD","LU0128525929.USD","LU0122379950.USD","LU1244550494.USD","LU0198837287.USD","BK4588","LU2089283258.USD","IE00B4R5TH58.HKD","LU0310799852.SGD","LU1718418525.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","LU2089984988.USD","LU1989771016.USD","LU2129689431.USD","LU1934455277.USD","LU2133065610.SGD","LU0965509010.AUD","IE00BDGV0183.EUR","LU1585245621.USD","IE00BN8TJ469.HKD","IE00BGHQF631.EUR","LU0310800379.SGD","SG9999003800.SGD","BK4559","LU0553294199.USD","LU0029864427.USD","LU0417517546.SGD","IE00BLSP4452.SGD","BK4139","SG9999001440.SGD","LU0432979614.USD","SG9999011175.SGD","BK4550","LU0211327993.USD"],"gpt_icon":0},{"id":"1166070393","title":"Rinvoq® (Upadacitinib) 在类风湿性关节炎患者中显示出比 Humira® (Adalimumab) 在主要终点上的优越性","url":"https://stock-news.laohu8.com/highlight/detail?id=1166070393","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166070393?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:01","pubTimestamp":1760961699,"startTime":"0","endTime":"0","summary":"Rinvoq® (Upadacitinib) 在类风湿性关节炎患者中，与首次使用 TNF 抑制剂失败的患者进行的对照研究中，显示出其在主要终点上的优越性，超越了 Humira® (Adalimumab)。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","SG9999003800.SGD","LU2129689431.USD","LU0198837287.USD","LU0949170772.SGD","IE00BVYPNW00.USD","LU0432979614.USD","LU2237443978.SGD","LU1244550577.SGD","IE00B3PB1722.GBP","LU0965509283.SGD","LU1732799900.SGD","LU0738911758.USD","LU0310800379.SGD","SG9999015986.USD","LU1585245621.USD","LU1983299246.USD","LU0203347892.USD","LU0689626769.HKD","LU1074936037.SGD","LU1551013342.USD","LU0289739699.SGD","LU0965509010.AUD","LU1162221912.USD","LU0820561818.USD","LU2133065610.SGD","LU0122379950.USD","LU0203345920.USD","LU1934455863.HKD","LU1023059063.AUD","LU0861579265.USD","LU0234572021.USD","LU0943347566.SGD","LU0795875086.SGD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0320765646.SGD","LU1718418525.SGD","BK4588","IE00B2B36J28.USD","LU0158827948.USD","BK4139","BK4550","SG9999015952.SGD","LU1732800096.USD","IE00BLSP4452.SGD","IE00BGHQF631.EUR","LU1989771016.USD","LU1037948541.HKD","LU2023251221.USD","LU0985320562.USD","LU1291159041.SGD","LU1037948897.HKD","LU0553294199.USD","LU2087621335.USD","LU0170899867.USD","LU1267930490.SGD","LU1839511570.USD","IE00B42XCP33.USD","IE00BN8TJ469.HKD","LU2237443549.SGD","LU0128525929.USD","LU0256863902.USD","LU2237443465.HKD","BK4534","LU2237443382.USD","LU2237443895.HKD","LU0708994859.HKD","LU0689472784.USD","ABBV","LU1244550221.USD","LU0545039389.USD","LU0661504455.SGD","LU0965508806.USD","LU1003077747.HKD","LU0124676726.USD","SG9999015978.USD","IE0002270589.USD","LU1989772840.SGD","IE00BVYPNV92.GBP","LU1934455277.USD","LU0965509101.SGD","IE00BFTCPJ56.SGD","LU0417517546.SGD","SG9999011175.SGD","LU1061106388.HKD","LU0795875169.SGD","BK4559","LU0820561909.HKD","BK4581","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0211327993.USD","LU1496350502.SGD","LU0310799852.SGD","LU1057294990.SGD","LU2468319806.SGD","LU2129689514.USD","SG9999001440.SGD","LU1934455194.USD","IE00B19Z3581.USD","LU0256863811.USD","LU1551013425.SGD","IE00BLSP4239.USD","LU1267930573.SGD","LU2347655156.SGD","LU1093756168.USD","LU2129689605.HKD","IE0002141913.USD","BK4533","LU0211328371.USD","LU0029864427.USD","IE00BBT3K403.USD","IE00BSNM7G36.USD","LU2089284900.SGD","LU0114720955.EUR","LU0882574055.USD","LU1929549753.HKD","LU0456855351.SGD","IE00B4R5TH58.HKD","BK4566","LU2089984988.USD","LU2089283258.USD","LU2237443622.USD","SG9999015945.SGD","LU1430594728.SGD","IE00BDGV0183.EUR","LU1496350171.SGD","LU1989772923.USD","LU0912757837.SGD","BK4585","IE0004445239.USD","LU1244550494.USD","LU0234570918.USD","LU2112291526.USD"],"gpt_icon":0},{"id":"2575234152","title":"艾伯维(ABBV.US)1类新药国内报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2575234152","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575234152?lang=zh_cn&edition=full","pubTime":"2025-10-14 08:12","pubTimestamp":1760400754,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，10月13日，CDE官网显示，艾伯维注射用E型肉毒毒素上市申请获受理，注册分类为1类。根据公开资料和临床试验进展，Insight数据库推测适应症为中度至重度眉间纹。III期研究的所有主要和次要终点均已达到，给药后8小时即可快速起效，且疗效持续时间为2-3周。此外，无论是作为单次治疗还是最多连续三次治疗，TrenibotE的治疗中出现的不良事件与安慰剂相似。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1354568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维(ABBV.US)1类新药国内报上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1732799900.SGD","LU1037948541.HKD","LU0545039389.USD","LU2129689605.HKD","LU1291159041.SGD","LU0310800379.SGD","BK4550","BK4533","LU0820561909.HKD","LU2237443978.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","LU1267930573.SGD","IE00B19Z3581.USD","LU1929549753.HKD","LU0122379950.USD","LU0029864427.USD","LU1244550577.SGD","LU0158827948.USD","LU0795875169.SGD","LU1989772923.USD","BK4581","IE00BLSP4452.SGD","LU1934455277.USD","LU0456855351.SGD","LU2347655156.SGD","LU0320765646.SGD","LU0211328371.USD","IE00B19Z3B42.SGD","LU0949170772.SGD","LU1162221912.USD","LU0234572021.USD","LU1074936037.SGD","BK4585","IE00BSNM7G36.USD","LU2237443549.SGD","LU2087621335.USD","LU0861579265.USD","IE00BJJMRZ35.SGD","IE00B3PB1722.GBP","LU0128525929.USD","LU0882574055.USD","LU1057294990.SGD","LU0738911758.USD","SG9999015978.USD","LU1989771016.USD","IE0004445239.USD","LU1093756168.USD","LU2237443895.HKD","ABBV"],"gpt_icon":0},{"id":"1116648517","title":"美国食品药品监督管理局(FDA)批准Rinvoq®(乌帕替尼)治疗炎症性肠病的更新适应症声明","url":"https://stock-news.laohu8.com/highlight/detail?id=1116648517","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116648517?lang=zh_cn&edition=full","pubTime":"2025-10-13 23:00","pubTimestamp":1760367624,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)批准Rinvoq®(乌帕替尼)治疗炎症性肠病的更新适应症声明","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0545039389.USD","LU1291159041.SGD","LU0203347892.USD","BK4533","LU0820561909.HKD","LU2237443978.SGD","LU2133065610.SGD","LU0234570918.USD","BK4566","IE00BLSP4239.USD","LU1551013425.SGD","BK4559","BK4581","LU0661504455.SGD","LU0456855351.SGD","LU1839511570.USD","LU1983299246.USD","IE00B19Z3B42.SGD","LU2468319806.SGD","LU1162221912.USD","LU2023251221.USD","BK4585","IE00BGHQF631.EUR","LU1037948897.HKD","LU1496350171.SGD","LU2237443549.SGD","LU1718418525.SGD","LU0861579265.USD","IE00B2B36J28.USD","LU1989772840.SGD","IE00B3PB1722.GBP","BK4139","LU0128525929.USD","LU0882574055.USD","LU1267930490.SGD","LU0965509101.SGD","LU1023059063.AUD","SG9999001440.SGD","LU1585245621.USD","LU0058720904.USD","LU2237443895.HKD","LU1037948541.HKD","LU2089284900.SGD","LU1551013342.USD","IE0002141913.USD","LU0985320562.USD","IE00B19Z3581.USD","BK4534","LU0029864427.USD","LU0158827948.USD","LU0795875169.SGD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","LU2237443622.USD","LU0211328371.USD","LU1430594728.SGD","LU2129689514.USD","LU0211327993.USD","IE00BJJMRZ35.SGD","LU2237443382.USD","LU0553294199.USD","LU0820561818.USD","LU1989771016.USD","IE0004445239.USD","LU0912757837.SGD","LU0943347566.SGD","LU0965509283.SGD","LU0795875086.SGD","ABBV","LU0310800379.SGD","BK4550","SG9999015952.SGD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU1929549753.HKD","IE00B42XCP33.USD","LU0432979614.USD","LU1244550577.SGD","LU2129689431.USD","SG9999015986.USD","LU1989772923.USD","LU1934455277.USD","LU1496350502.SGD","LU0965509010.AUD","LU2347655156.SGD","LU0320765646.SGD","LU1934455194.USD","LU0949170772.SGD","LU2089984988.USD","LU0234572021.USD","LU1244550221.USD","IE00BSNM7G36.USD","SG9999011175.SGD","SG9999003800.SGD","IE0002270589.USD","IE00BVYPNW00.USD","IE0009355771.USD","LU1061106388.HKD","LU1003077747.HKD","LU1057294990.SGD","LU2089283258.USD","LU0289739699.SGD","IE00BDGV0183.EUR","LU0203345920.USD","BK4588","LU0198837287.USD","LU2112291526.USD","LU1732799900.SGD","LU2129689605.HKD","LU0965508806.USD","LU0708994859.HKD","LU0689472784.USD","LU0122379950.USD","LU1934455863.HKD","LU1732800096.USD","IE00BVYPNV92.GBP","IE00BBT3K403.USD","SG9999015945.SGD","LU1093756325.SGD","LU1074936037.SGD","LU1244550494.USD","LU0114720955.EUR","LU2087621335.USD","LU0310799852.SGD","LU0256863902.USD","LU0417517546.SGD","LU0170899867.USD","LU0738911758.USD","LU0256863811.USD","SG9999015978.USD","LU1093756168.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"1187587941","title":"艾伯维公司公布第二期Elate临床试验积极的主要结果，评估Onabotulinumtoxina（Botox®）治疗上肢特发性震颤","url":"https://stock-news.laohu8.com/highlight/detail?id=1187587941","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187587941?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:03","pubTimestamp":1759755829,"startTime":"0","endTime":"0","summary":"艾伯维公司公布第二期Elate临床试验积极的主要结果，评估Onabotulinumtoxina（Botox®）治疗上肢特发性震颤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003077747.HKD","SG9999011175.SGD","LU0211327993.USD","IE00BJJMRZ35.SGD","IE0004445239.USD","LU1093756168.USD","IE00BVYPNW00.USD","SG9999001440.SGD","LU1839511570.USD","LU2089984988.USD","LU2089284900.SGD","LU2087621335.USD","IE00B42XCP33.USD","LU1244550494.USD","LU1585245621.USD","SG9999015986.USD","LU1983299246.USD","LU2129689605.HKD","LU0170899867.USD","IE0002141913.USD","LU1496350171.SGD","BK4559","LU0943347566.SGD","LU0965509101.SGD","LU0203345920.USD","BK4566","LU0949170772.SGD","LU1989772840.SGD","LU0198837287.USD","LU1244550577.SGD","LU0545039389.USD","IE00B4R5TH58.HKD","LU0708994859.HKD","LU1551013425.SGD","LU0158827948.USD","LU1057294990.SGD","LU0256863811.USD","LU1934455863.HKD","LU0310800379.SGD","LU1551013342.USD","LU0320765646.SGD","LU2237443978.SGD","IE00BLSP4239.USD","IE00BN8TJ469.HKD","LU2023251221.USD","LU0965509283.SGD","LU2133065610.SGD","LU0456855351.SGD","LU1074936037.SGD","LU1929549753.HKD","LU2237443382.USD","LU1989771016.USD","ABBV","IE00BBT3K403.USD","LU0211328371.USD","LU1732800096.USD","LU2347655156.SGD","LU1989772923.USD","LU1732799900.SGD","LU2129689431.USD","IE00B3PB1722.GBP","IE00BLSP4452.SGD","LU0965509010.AUD","LU0985320562.USD","LU2237443465.HKD","LU2129689514.USD","LU1037948541.HKD","LU1267930490.SGD","SG9999003800.SGD","IE00BVYPNV92.GBP","LU1934455277.USD","LU0820561909.HKD","LU0128525929.USD","IE0009355771.USD","LU2237443895.HKD","LU0310799852.SGD","LU2468319806.SGD","BK4139","IE00B19Z3581.USD","LU0965508806.USD","LU2089283258.USD","IE00BDGV0183.EUR","LU0795875169.SGD","LU0738911758.USD","IE00BSNM7G36.USD","LU1037948897.HKD","LU2112291526.USD","IE00B2B36J28.USD","BK4534","SG9999015945.SGD","LU0256863902.USD","LU2237443549.SGD","LU0861579265.USD","LU0122379950.USD","LU0234572021.USD","LU0203347892.USD","IE00BGHQF631.EUR","BK4585","LU1934455194.USD","SG9999015978.USD","LU0234570918.USD","LU0689472784.USD","BK4533","LU0058720904.USD","IE0002270589.USD","SG9999015952.SGD","LU1244550221.USD","LU0029864427.USD","LU0795875086.SGD","LU1291159041.SGD","LU0912757837.SGD","LU2237443622.USD","LU1061106388.HKD","BK4581","LU0553294199.USD","IE00BJT1NW94.SGD","LU1718418525.SGD","IE00BFTCPJ56.SGD","LU1093756325.SGD","BK4550","LU1496350502.SGD","LU0661504455.SGD","LU0432979614.USD","LU1430594728.SGD","IE00B19Z3B42.SGD","LU0882574055.USD","LU1023059063.AUD","LU0417517546.SGD","LU0289739699.SGD","LU0820561818.USD","LU1162221912.USD","LU1267930573.SGD","BK4588","LU0114720955.EUR"],"gpt_icon":0},{"id":"1175136878","title":"艾伯维公司：Onabotulinumtoxina安全性结果与其已确立的安全特征保持一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1175136878","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175136878?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:03","pubTimestamp":1759755816,"startTime":"0","endTime":"0","summary":"艾伯维公司表示，Onabotulinumtoxina的安全性结果与其已确立的安全特征保持一致。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732800096.USD","BK4588","LU1291159041.SGD","BK4534","LU1003077747.HKD","IE00BDGV0183.EUR","IE00BJJMRZ35.SGD","IE00BN8TJ469.HKD","LU0553294199.USD","LU1934455863.HKD","IE00B4R5TH58.HKD","LU1989772923.USD","IE00B19Z3581.USD","LU0029864427.USD","LU2237443465.HKD","LU1934455194.USD","LU0708994859.HKD","LU1037948897.HKD","IE0002270589.USD","LU0795875169.SGD","LU0289739699.SGD","IE00BVYPNW00.USD","LU2089284900.SGD","IE00BGHQF631.EUR","ABBV","LU2089283258.USD","LU1983299246.USD","SG9999011175.SGD","BK4581","LU1839511570.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","SG9999015986.USD","LU0432979614.USD","LU1732799900.SGD","LU2129689605.HKD","SG9999015945.SGD","LU0912757837.SGD","BK4566","LU1934455277.USD","LU1585245621.USD","LU2237443895.HKD","BK4550","LU1267930490.SGD","LU0211328371.USD","BK4585","IE0002141913.USD","IE0009355771.USD","LU0965509010.AUD","LU2129689431.USD","LU1496350502.SGD","LU2237443622.USD","LU1093756325.SGD","LU0417517546.SGD","LU0965509101.SGD","LU0128525929.USD","LU2129689514.USD","SG9999001440.SGD","BK4559","LU1093756168.USD","LU2112291526.USD","LU1037948541.HKD","LU1989772840.SGD","LU0158827948.USD","LU1929549753.HKD","LU1244550577.SGD","LU1430594728.SGD","LU0234570918.USD","LU2023251221.USD","LU1551013342.USD","IE00BBT3K403.USD","LU2237443978.SGD","LU2468319806.SGD","LU0456855351.SGD","LU0122379950.USD","LU1718418525.SGD","LU0861579265.USD","LU1989771016.USD","LU0820561909.HKD","BK4533","IE00BFTCPJ56.SGD","LU0545039389.USD","LU0882574055.USD","LU0738911758.USD","LU0943347566.SGD","LU0211327993.USD","LU0058720904.USD","LU0198837287.USD","LU2347655156.SGD","LU1496350171.SGD","IE00B42XCP33.USD","SG9999003800.SGD","IE00B3PB1722.GBP","LU0795875086.SGD","LU0985320562.USD","LU0170899867.USD","LU0310799852.SGD","LU1074936037.SGD","IE00BLSP4239.USD","LU0965508806.USD","LU0114720955.EUR","BK4139","IE00BSNM7G36.USD","IE00BLSP4452.SGD","LU1551013425.SGD","LU0234572021.USD","LU1057294990.SGD","SG9999015978.USD","LU2133065610.SGD","LU0949170772.SGD","LU0203347892.USD","LU0689472784.USD","IE00B2B36J28.USD","LU1267930573.SGD","LU0310800379.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","LU0661504455.SGD","LU0965509283.SGD","LU1244550221.USD","LU0203345920.USD","LU0256863811.USD","LU1244550494.USD","LU1162221912.USD","LU0820561818.USD","LU0320765646.SGD","SG9999015952.SGD","IE00BVYPNV92.GBP","LU2087621335.USD","LU1061106388.HKD","LU2237443382.USD","IE0004445239.USD","LU0256863902.USD","LU2237443549.SGD"],"gpt_icon":0},{"id":"1111526751","title":"艾伯维公司2025年全年调整后每股收益预期范围（含知识产权研发影响）为10.38-10.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111526751","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111526751?lang=zh_cn&edition=full","pubTime":"2025-10-04 04:11","pubTimestamp":1759522281,"startTime":"0","endTime":"0","summary":"根据向证券交易委员会提交的文件显示，艾伯维公司公布了2025年全年调整后每股收益指导范围，包含知识产权研发影响在内的预期区间为10.38美元至10.58美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE00BDGV0183.EUR","LU0128525929.USD","IE00BJT1NW94.SGD","LU2129689514.USD","LU2089283258.USD","LU0234570918.USD","LU2087621335.USD","IE00BLSP4452.SGD","LU2237443622.USD","LU1983299246.USD","BK4585","SG9999015952.SGD","LU0965508806.USD","LU0198837287.USD","IE00B42XCP33.USD","LU0114720955.EUR","LU0456855351.SGD","LU0795875086.SGD","LU0965509283.SGD","LU1244550577.SGD","LU1732800096.USD","LU0882574055.USD","LU0234572021.USD","LU2468319806.SGD","LU0912757837.SGD","LU2347655156.SGD","LU1003077747.HKD","LU1093756168.USD","BK4566","LU0661504455.SGD","IE00BJJMRZ35.SGD","LU1551013342.USD","LU2237443382.USD","LU0861579265.USD","LU2023251221.USD","LU1037948541.HKD","IE00BSNM7G36.USD","IE0009355771.USD","LU0158827948.USD","BK4581","LU0310799852.SGD","LU0545039389.USD","LU0943347566.SGD","LU1585245621.USD","LU0203345920.USD","IE0002141913.USD","LU0965509101.SGD","LU0820561909.HKD","LU1267930573.SGD","LU0203347892.USD","LU0820561818.USD","LU1732799900.SGD","SG9999001440.SGD","LU2133065610.SGD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU0256863902.USD","LU0985320562.USD","LU1934455863.HKD","LU2089984988.USD","LU0029864427.USD","SG9999015978.USD","BK4533","LU1037948897.HKD","LU1929549753.HKD","IE00BLSP4239.USD","LU1267930490.SGD","IE00B19Z3581.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","LU1162221912.USD","IE00BVYPNV92.GBP","LU0417517546.SGD","LU1244550221.USD","LU1093756325.SGD","ABBV","LU0211328371.USD","LU1061106388.HKD","IE00B3PB1722.GBP","LU2112291526.USD","LU1934455194.USD","LU0553294199.USD","LU0949170772.SGD","LU2237443465.HKD","BK4550","LU0795875169.SGD","LU0122379950.USD","LU1839511570.USD","LU0211327993.USD","LU1989771016.USD","BK4139","BK4559","LU1934455277.USD","LU1989772923.USD","LU0310800379.SGD","LU0058720904.USD","LU1074936037.SGD","IE00B2B36J28.USD","BK4534","IE00BN8TJ469.HKD","LU2129689605.HKD","LU1244550494.USD","LU0170899867.USD","LU1551013425.SGD","LU1430594728.SGD","LU0965509010.AUD","IE0002270589.USD","LU1496350171.SGD","LU2237443549.SGD","IE0004445239.USD","LU0738911758.USD","LU0708994859.HKD","BK4588","LU0432979614.USD","LU0320765646.SGD","LU1057294990.SGD","SG9999003800.SGD","SG9999015986.USD","LU0289739699.SGD","IE00BBT3K403.USD","LU1291159041.SGD","LU2129689431.USD","LU1718418525.SGD","LU2237443895.HKD","LU0256863811.USD","LU1989772840.SGD","IE00BVYPNW00.USD","SG9999015945.SGD","LU2237443978.SGD","LU2089284900.SGD","LU0689472784.USD","LU1496350502.SGD"],"gpt_icon":0},{"id":"1165248126","title":"艾伯维公司启动7000万美元扩建项目 进一步增强美国生物制药制造和研发实力","url":"https://stock-news.laohu8.com/highlight/detail?id=1165248126","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165248126?lang=zh_cn&edition=full","pubTime":"2025-10-01 03:01","pubTimestamp":1759258874,"startTime":"0","endTime":"0","summary":"艾伯维公司启动7000万美元扩建项目，进一步增强美国生物制药制造和研发实力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","BK4533","LU1929549753.HKD","LU0965509283.SGD","LU1496350502.SGD","LU2112291526.USD","BK4550","IE00B19Z3B42.SGD","LU0912757837.SGD","LU0545039389.USD","LU1093756168.USD","IE00BFTCPJ56.SGD","LU0234572021.USD","LU1983299246.USD","LU1057294990.SGD","LU0661504455.SGD","LU0861579265.USD","LU0965509101.SGD","LU1732799900.SGD","IE00BBT3K403.USD","LU1551013425.SGD","LU2468319806.SGD","LU2237443978.SGD","BK4559","LU1162221912.USD","SG9999015945.SGD","LU0058720904.USD","LU1003077747.HKD","IE00B42XCP33.USD","LU1061106388.HKD","LU2129689431.USD","LU2237443382.USD","LU0795875086.SGD","LU1732800096.USD","BK4534","ABBV","BK4585","IE00BVYPNW00.USD","LU0211328371.USD","LU1585245621.USD","LU1093756325.SGD","LU1496350171.SGD","LU1244550221.USD","LU2089984988.USD","IE00B2B36J28.USD","LU1244550577.SGD","IE0004445239.USD","IE00BJT1NW94.SGD","IE00BDGV0183.EUR","LU2347655156.SGD","IE00BLSP4239.USD","LU0310800379.SGD","LU0289739699.SGD","BK4581","LU0820561818.USD","LU0689472784.USD","LU0122379950.USD","LU0417517546.SGD","LU1839511570.USD","LU0943347566.SGD","LU0170899867.USD","LU2133065610.SGD","LU2237443622.USD","LU0029864427.USD","LU1023059063.AUD","LU0738911758.USD","LU1244550494.USD","IE00B19Z3581.USD","IE0002141913.USD","LU0985320562.USD","LU0310799852.SGD","LU0553294199.USD","SG9999003800.SGD","LU2129689605.HKD","LU0708994859.HKD","IE00BVYPNV92.GBP","LU0158827948.USD","LU0949170772.SGD","IE00BN8TJ469.HKD","LU0234570918.USD","LU0320765646.SGD","LU1267930573.SGD","BK4139","LU2129689514.USD","SG9999015952.SGD","LU2087621335.USD","LU0795875169.SGD","LU2023251221.USD","LU0456855351.SGD","LU1934455277.USD","SG9999011175.SGD","LU1989771016.USD","LU0256863902.USD","LU2237443465.HKD","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","LU0198837287.USD","LU0203347892.USD","LU0211327993.USD","SG9999001440.SGD","SG9999015978.USD","BK4566","LU0882574055.USD","LU1037948897.HKD","IE00BSNM7G36.USD","LU0203345920.USD","SG9999015986.USD","LU2089284900.SGD","LU1934455194.USD","LU2237443895.HKD","IE0002270589.USD","BK4588","LU1074936037.SGD","LU1934455863.HKD","IE0009355771.USD","LU1718418525.SGD","LU0820561909.HKD","LU0432979614.USD","LU2237443549.SGD","LU1291159041.SGD","LU0965509010.AUD","LU0114720955.EUR","LU1430594728.SGD","LU1989772840.SGD","LU0965508806.USD","LU1989772923.USD","LU2089283258.USD","LU1037948541.HKD","LU1551013342.USD","LU0128525929.USD","IE00BLSP4452.SGD","IE00B3PB1722.GBP","LU1267930490.SGD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"1190402084","title":"AbbVie向美国FDA提交Pivekimab Sunirine (PVEK)生物制品许可申请 - 用于治疗治疗选择有限的罕见癌症的研究性抗体药物偶联物(ADC)","url":"https://stock-news.laohu8.com/highlight/detail?id=1190402084","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190402084?lang=zh_cn&edition=full","pubTime":"2025-09-30 20:02","pubTimestamp":1759233741,"startTime":"0","endTime":"0","summary":"AbbVie向美国FDA提交Pivekimab Sunirine (PVEK)生物制品许可申请 - 用于治疗治疗选择有限的罕见癌症的研究性抗体药物偶联物(ADC)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","LU1074936037.SGD","IE00BVYPNW00.USD","IE00B2B36J28.USD","LU0912757837.SGD","LU0158827948.USD","LU2129689431.USD","LU0861579265.USD","LU1718418525.SGD","LU0289739699.SGD","LU0234570918.USD","LU0795875169.SGD","BK4550","IE00B19Z3B42.SGD","LU1162221912.USD","LU1989771016.USD","LU2237443465.HKD","BK4585","LU2087621335.USD","LU1037948897.HKD","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","LU0029864427.USD","LU1061106388.HKD","LU0432979614.USD","LU0122379950.USD","IE00BVYPNV92.GBP","SG9999001440.SGD","LU0203345920.USD","LU2089283258.USD","IE00B19Z3581.USD","LU1003077747.HKD","LU2133065610.SGD","LU2089284900.SGD","IE0004445239.USD","LU0234572021.USD","LU1023059063.AUD","LU1244550494.USD","IE00B3PB1722.GBP","LU0203347892.USD","LU0708994859.HKD","IE00BN8TJ469.HKD","LU0128525929.USD","LU1983299246.USD","IE00BJT1NW94.SGD","IE0002270589.USD","LU0256863902.USD","SG9999015978.USD","LU0310800379.SGD","LU1093756168.USD","IE00BLSP4452.SGD","LU0211327993.USD","BK4533","LU2129689605.HKD","LU1585245621.USD","IE00BDGV0183.EUR","LU0965509101.SGD","BK4139","LU1244550577.SGD","LU1934455863.HKD","LU1496350171.SGD","LU0198837287.USD","LU0545039389.USD","LU1093756325.SGD","LU1551013425.SGD","IE00BBT3K403.USD","LU1037948541.HKD","LU1732800096.USD","LU1244550221.USD","BK4566","LU2237443895.HKD","BK4534","LU2468319806.SGD","LU2237443549.SGD","LU1291159041.SGD","LU0985320562.USD","LU1732799900.SGD","LU1839511570.USD","LU1551013342.USD","IE00BJJMRZ35.SGD","LU2237443978.SGD","LU0965509010.AUD","LU1934455194.USD","LU0417517546.SGD","IE0002141913.USD","LU0820561909.HKD","BK4559","LU1989772923.USD","LU0553294199.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BGHQF631.EUR","LU0820561818.USD","LU0211328371.USD","IE00B42XCP33.USD","LU1430594728.SGD","SG9999011175.SGD","LU0320765646.SGD","LU0114720955.EUR","LU0882574055.USD","LU0795875086.SGD","LU0310799852.SGD","ABBV","LU1267930490.SGD","LU1934455277.USD","LU0170899867.USD","LU0058720904.USD","LU2347655156.SGD","LU1267930573.SGD","LU1057294990.SGD","LU0965509283.SGD","LU1989772840.SGD","LU0689472784.USD","LU2112291526.USD","SG9999015986.USD","SG9999015952.SGD","LU1496350502.SGD","LU2129689514.USD","SG9999003800.SGD","LU0456855351.SGD","LU2237443622.USD","LU0256863811.USD","LU0965508806.USD","BK4581","LU1929549753.HKD","LU2089984988.USD","LU0943347566.SGD","LU2023251221.USD","LU0661504455.SGD","LU0949170772.SGD","LU0738911758.USD","SG9999015945.SGD","BK4588","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"1171009810","title":"艾伯维公司向美国FDA提交Tavapadon新药申请，用于治疗帕金森病","url":"https://stock-news.laohu8.com/highlight/detail?id=1171009810","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171009810?lang=zh_cn&edition=full","pubTime":"2025-09-26 20:46","pubTimestamp":1758890810,"startTime":"0","endTime":"0","summary":"艾伯维公司向美国FDA提交Tavapadon新药申请，用于治疗帕金森病","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732800096.USD","BK4588","LU1291159041.SGD","BK4534","LU1003077747.HKD","IE00BDGV0183.EUR","IE00BJJMRZ35.SGD","IE00BN8TJ469.HKD","LU0553294199.USD","LU1934455863.HKD","IE00B4R5TH58.HKD","LU1989772923.USD","IE00B19Z3581.USD","LU0029864427.USD","LU2237443465.HKD","LU1934455194.USD","LU0708994859.HKD","LU1037948897.HKD","IE0002270589.USD","LU0795875169.SGD","LU0289739699.SGD","IE00BVYPNW00.USD","LU2089284900.SGD","IE00BGHQF631.EUR","ABBV","LU2089283258.USD","LU1983299246.USD","SG9999011175.SGD","BK4581","LU1839511570.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","SG9999015986.USD","LU0432979614.USD","LU1732799900.SGD","LU2129689605.HKD","SG9999015945.SGD","LU0912757837.SGD","BK4566","LU1934455277.USD","LU1585245621.USD","LU2237443895.HKD","BK4550","LU1267930490.SGD","LU0211328371.USD","BK4585","IE0002141913.USD","IE0009355771.USD","LU0965509010.AUD","LU2129689431.USD","LU1496350502.SGD","LU2237443622.USD","LU1093756325.SGD","LU0417517546.SGD","LU0965509101.SGD","LU0128525929.USD","LU2129689514.USD","SG9999001440.SGD","BK4559","LU1093756168.USD","LU2112291526.USD","LU1037948541.HKD","LU1989772840.SGD","LU0158827948.USD","LU1929549753.HKD","LU1244550577.SGD","LU1430594728.SGD","LU0234570918.USD","LU2023251221.USD","LU1551013342.USD","IE00BBT3K403.USD","LU2237443978.SGD","LU2468319806.SGD","LU0456855351.SGD","LU0122379950.USD","LU1718418525.SGD","LU0861579265.USD","LU1989771016.USD","LU0820561909.HKD","BK4533","IE00BFTCPJ56.SGD","LU0545039389.USD","LU0882574055.USD","LU0738911758.USD","LU0943347566.SGD","LU0211327993.USD","LU0058720904.USD","LU0198837287.USD","LU2347655156.SGD","LU1496350171.SGD","IE00B42XCP33.USD","SG9999003800.SGD","IE00B3PB1722.GBP","LU0795875086.SGD","LU0985320562.USD","LU0170899867.USD","LU0310799852.SGD","LU1074936037.SGD","IE00BLSP4239.USD","LU0965508806.USD","LU0114720955.EUR","BK4139","IE00BSNM7G36.USD","IE00BLSP4452.SGD","LU1551013425.SGD","LU0234572021.USD","LU1057294990.SGD","SG9999015978.USD","LU2133065610.SGD","LU0949170772.SGD","LU0203347892.USD","LU0689472784.USD","IE00B2B36J28.USD","LU1267930573.SGD","LU0310800379.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","LU0661504455.SGD","LU0965509283.SGD","LU1244550221.USD","LU0203345920.USD","LU0256863811.USD","LU1244550494.USD","LU1162221912.USD","LU0820561818.USD","LU0320765646.SGD","SG9999015952.SGD","IE00BVYPNV92.GBP","LU2087621335.USD","LU1061106388.HKD","LU2237443382.USD","IE0004445239.USD","LU0256863902.USD","LU2237443549.SGD"],"gpt_icon":0},{"id":"1150461459","title":"Qulipta®（阿托司潘）现已在魁北克省获得慢性偏头痛公共报销，CGRP类药物审查已发布","url":"https://stock-news.laohu8.com/highlight/detail?id=1150461459","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150461459?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:02","pubTimestamp":1758798160,"startTime":"0","endTime":"0","summary":"Qulipta®（阿托司潘）现已在魁北克省获得慢性偏头痛公共报销，CGRP类药物审查已发布","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","LU0211328371.USD","LU2237443622.USD","IE00B19Z3B42.SGD","IE00BJJMRZ35.SGD","SG9999015952.SGD","LU2468319806.SGD","BK4585","LU2089284900.SGD","IE00BLSP4239.USD","LU1929549753.HKD","LU1989771016.USD","SG9999001440.SGD","LU1430594728.SGD","LU2237443549.SGD","LU0985320562.USD","BK4581","LU1061106388.HKD","LU0158827948.USD","LU0456855351.SGD","LU0708994859.HKD","LU0738911758.USD","LU2089984988.USD","LU0820561909.HKD","IE0002270589.USD","LU0310799852.SGD","LU0965509010.AUD","LU1037948897.HKD","LU1267930573.SGD","SG9999003800.SGD","IE00BSNM7G36.USD","LU0029864427.USD","LU0114720955.EUR","LU2129689431.USD","BK4566","LU0203347892.USD","IE00B19Z3581.USD","LU1093756325.SGD","LU0545039389.USD","LU1983299246.USD","BK4534","LU0820561818.USD","LU0949170772.SGD","LU0795875086.SGD","LU1267930490.SGD","LU2129689514.USD","BK4550","LU0553294199.USD","LU0058720904.USD","LU1291159041.SGD","LU0256863811.USD","IE00BFTCPJ56.SGD","LU0861579265.USD","LU0203345920.USD","LU0882574055.USD","LU1093756168.USD","LU2237443978.SGD","LU0122379950.USD","SG9999015986.USD","IE00BVYPNW00.USD","IE00B2B36J28.USD","LU2347655156.SGD","LU0289739699.SGD","LU0310800379.SGD","BK4533","LU1551013425.SGD","LU2089283258.USD","LU1244550221.USD","LU1839511570.USD","LU1989772923.USD","LU1074936037.SGD","LU1244550494.USD","LU1934455194.USD","LU0256863902.USD","SG9999011175.SGD","IE00B4R5TH58.HKD","LU0198837287.USD","IE00BDGV0183.EUR","LU0943347566.SGD","LU1934455863.HKD","LU1934455277.USD","SG9999015945.SGD","LU1003077747.HKD","LU2129689605.HKD","LU1057294990.SGD","IE00BBT3K403.USD","IE00BGHQF631.EUR","LU2023251221.USD","LU2237443895.HKD","IE00BLSP4452.SGD","LU0417517546.SGD","LU0965509283.SGD","LU0795875169.SGD","LU1162221912.USD","IE0002141913.USD","LU0965509101.SGD","LU1989772840.SGD","LU1037948541.HKD","LU1585245621.USD","LU0211327993.USD","IE0004445239.USD","LU1718418525.SGD","IE00BJT1NW94.SGD","LU1732800096.USD","IE00B42XCP33.USD","LU1244550577.SGD","LU1023059063.AUD","LU0661504455.SGD","BK4559","LU2133065610.SGD","BK4139","LU0128525929.USD","LU0965508806.USD","ABBV","LU0912757837.SGD","BK4588","LU2237443382.USD","IE00BN8TJ469.HKD","LU1496350502.SGD","LU0320765646.SGD","LU0689472784.USD","LU1496350171.SGD","IE0009355771.USD","LU0170899867.USD","SG9999015978.USD","LU0234572021.USD","LU0432979614.USD","LU2112291526.USD","LU0234570918.USD","LU2087621335.USD","IE00B3PB1722.GBP","IE00BVYPNV92.GBP","LU2237443465.HKD","LU1551013342.USD"],"gpt_icon":0},{"id":"2569631778","title":"艾伯维(ABBV.US)旗下艾可瑞妥单抗在华申报新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2569631778","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569631778?lang=zh_cn&edition=full","pubTime":"2025-09-24 14:40","pubTimestamp":1758696047,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月23日，药品审评中心网站显示，艾伯维的艾可瑞妥单抗注射液在华申报新适应症。根据优先审评进展，本次申报的适应症为联合利妥昔单抗和来那度胺治疗复发或难治性滤泡性淋巴瘤成人患者。艾可瑞妥单抗联合治疗组的ORR达95.7%，PFS风险比为0.21，疾病进展或死亡风险降低79%。美国FDA已受理艾可瑞妥单抗用于该适应症的sBLA并授予优先审评资格，PDUFA日期为2025年11月30 日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1348839.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2468319806.SGD","LU0310799852.SGD","IE00BJT1NW94.SGD","LU1093756168.USD","LU1093756325.SGD","LU2089984988.USD","LU0432979614.USD","BK4550","BK4139","LU2237443465.HKD","LU1732799900.SGD","LU0861579265.USD","ABBV","LU1839511570.USD","BK4533","LU1057294990.SGD","IE00B3PB1722.GBP","IE00BVYPNV92.GBP","LU0320765646.SGD","LU1267930490.SGD","SG9999015952.SGD","IE00BFTCPJ56.SGD","LU0949170772.SGD","LU2237443895.HKD","LU0965508806.USD","LU1585245621.USD","LU1061106388.HKD","LU0985320562.USD","LU0203347892.USD","LU2087621335.USD","LU1732800096.USD","LU0256863902.USD","LU1934455194.USD","LU2129689431.USD","LU2237443549.SGD","LU1929549753.HKD","LU0708994859.HKD","LU0661504455.SGD","LU0058720904.USD","LU1037948541.HKD","LU0795875086.SGD","IE00B42XCP33.USD","IE00BJJMRZ35.SGD","LU1496350171.SGD","LU2089283258.USD","IE0002270589.USD","SG9999015986.USD","LU0122379950.USD","LU1496350502.SGD","IE00BDGV0183.EUR"],"gpt_icon":0},{"id":"1172915105","title":"Allergan Aesthetics宣布将Skinvive by JuvÉDerm®扩展至35个新市场，进一步推进全球肌肤品质提升承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=1172915105","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172915105?lang=zh_cn&edition=full","pubTime":"2025-09-23 17:01","pubTimestamp":1758618119,"startTime":"0","endTime":"0","summary":"Allergan Aesthetics宣布将Skinvive by JuvÉDerm®扩展至35个新市场，进一步推进全球肌肤品质提升承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2112291526.USD","LU2468319806.SGD","LU0320765646.SGD","IE0004445239.USD","LU1093756325.SGD","LU1585245621.USD","LU2089984988.USD","LU2237443382.USD","ABBV","LU0456855351.SGD","IE00B42XCP33.USD","SG9999015952.SGD","LU1718418525.SGD","LU0234570918.USD","LU1291159041.SGD","IE00B3PB1722.GBP","LU1244550494.USD","BK4566","LU0211328371.USD","LU0158827948.USD","IE00B4R5TH58.HKD","LU0198837287.USD","LU2133065610.SGD","LU0170899867.USD","IE00BDGV0183.EUR","LU0203345920.USD","LU0861579265.USD","IE00B2B36J28.USD","LU2237443465.HKD","LU2087621335.USD","LU1934455863.HKD","LU1732799900.SGD","BK4533","LU0965509101.SGD","IE0009355771.USD","LU1496350171.SGD","LU0545039389.USD","LU0417517546.SGD","LU2089284900.SGD","BK4534","LU0738911758.USD","LU1430594728.SGD","BK4139","IE00BN8TJ469.HKD","LU2023251221.USD","IE00BVYPNV92.GBP","LU0289739699.SGD","LU1037948897.HKD","LU0432979614.USD","IE00BSNM7G36.USD","LU0256863811.USD","LU1037948541.HKD","LU0820561909.HKD","LU1003077747.HKD","LU2129689605.HKD","LU0114720955.EUR","LU0122379950.USD","IE0002270589.USD","LU0128525929.USD","LU0820561818.USD","LU1989772840.SGD","LU0310799852.SGD","LU1074936037.SGD","LU1162221912.USD","LU2237443895.HKD","IE00BLSP4452.SGD","LU0689472784.USD","LU1267930490.SGD","LU0661504455.SGD","IE00BBT3K403.USD","LU1551013425.SGD","SG9999003800.SGD","LU2237443978.SGD","LU2089283258.USD","LU1496350502.SGD","LU0795875169.SGD","LU1093756168.USD","BK4550","SG9999015978.USD","SG9999001440.SGD","LU1061106388.HKD","SG9999015945.SGD","LU2237443622.USD","LU1732800096.USD","IE00BJT1NW94.SGD","LU1934455194.USD","LU1057294990.SGD","SG9999015986.USD","LU1023059063.AUD","LU0058720904.USD","IE00BLSP4239.USD","LU1929549753.HKD","LU0882574055.USD","LU1989772923.USD","BK4581","LU2129689514.USD","LU0553294199.USD","IE00B19Z3B42.SGD","LU1989771016.USD","LU0203347892.USD","LU2237443549.SGD","LU0949170772.SGD","IE00BFTCPJ56.SGD","LU0943347566.SGD","LU2129689431.USD","LU0795875086.SGD","LU0234572021.USD","LU0256863902.USD","LU1244550577.SGD","IE00B19Z3581.USD","SG9999011175.SGD","LU1983299246.USD","LU0965509283.SGD","LU0211327993.USD","LU1551013342.USD","LU0965508806.USD","LU2347655156.SGD","LU0310800379.SGD","LU1244550221.USD","IE00BVYPNW00.USD","LU0985320562.USD","IE00BJJMRZ35.SGD","LU0912757837.SGD","LU0708994859.HKD","LU1934455277.USD","BK4588","BK4559","LU1267930573.SGD","LU0965509010.AUD","BK4585","LU0029864427.USD","IE0002141913.USD","LU1839511570.USD","IE00BGHQF631.EUR"],"gpt_icon":0},{"id":"2566942501","title":"艾伯维(ABBV.US)与仿制药企业就核心免疫药物Rinvoq达成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2566942501","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566942501?lang=zh_cn&edition=full","pubTime":"2025-09-12 11:22","pubTimestamp":1757647348,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾伯维公司于周四宣布，已与所有涉诉仿制药企业达成和解，解决了针对“仿制药企业计划推出Rinvoq仿制药”的相关诉讼。Rinvoq是艾伯维免疫治疗产品线中的核心药物。艾伯维在一份监管文件中表示，得益于此次达成的和解协议与授权协议，预计在2037年4月之前，针对Rinvoq片剂的仿制药不会进入美国市场。2025年上半年，Rinvoq的净销售额达到27亿美元，同比增长约53%;与之形成对比的是，同期修美乐在美国市场的销售额同比下滑约63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1344468.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾伯维(ABBV.US)与仿制药企业就核心免疫药物Rinvoq达成和解","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2133065610.SGD","SG9999003800.SGD","LU2089984988.USD","LU0211328371.USD","LU0861579265.USD","LU1732799900.SGD","LU0912757837.SGD","LU1585245621.USD","LU2129689514.USD","SG9999015952.SGD","LU1430594728.SGD","LU0738911758.USD","SG9999015986.USD","LU1496350171.SGD","BK4534","LU1989771016.USD","SG9999015978.USD","LU0158827948.USD","LU0128525929.USD","BK4550","SG9999011175.SGD","LU2237443895.HKD","IE00B2B36J28.USD","LU1267930573.SGD","LU2129689431.USD","BK4588","LU1267930490.SGD","LU1934455277.USD","LU2129689605.HKD","IE00BJJMRZ35.SGD","SG9999001440.SGD","SG9999015945.SGD","LU0432979614.USD","IE0004445239.USD","ABBV","IE0009355771.USD","LU0820561818.USD","LU0114720955.EUR","BK4559","LU0170899867.USD","LU0417517546.SGD","LU1003077747.HKD","LU1718418525.SGD","LU0965509283.SGD","IE00BVYPNV92.GBP","LU1093756168.USD","LU0965509101.SGD","LU0985320562.USD","IE00B19Z3581.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2566916557","title":"美股周四尾盘艾伯维(AbbVie,ABBV)股价上涨4.21%创该公司2012年从雅培实验室(ABT)拆分独立上市以来的","url":"https://stock-news.laohu8.com/highlight/detail?id=2566916557","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566916557?lang=zh_cn&edition=full","pubTime":"2025-09-12 03:27","pubTimestamp":1757618832,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1914381329.SGD","LU1983299246.USD","IE00BGHQF631.EUR","SG9999002224.SGD","LU0289739699.SGD","LU1839511570.USD","LU1267930490.SGD","LU1934455277.USD","LU2237443622.USD","LU1244550577.SGD","LU0545039389.USD","LU1023059063.AUD","SG9999015945.SGD","ABBV","LU0029864427.USD","LU0128525929.USD","LU1732799900.SGD","LU0122379950.USD","LU0912757837.SGD","LU1721429741.USD","IE00B19Z3581.USD","LU0882574055.USD","LU0234572021.USD","LU0417517546.SGD","LU1244550221.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","LU1989763690.USD","BK4568","SGXZ23171101.USD","LU1585245621.USD","BK4550","ABT.AU","LU0943347566.SGD","LU0738911758.USD","IE00BVYPNV92.GBP","IE0002141913.USD","LU0114720955.EUR","BK4588","LU0820561818.USD","LU2237443978.SGD","LU2347655156.SGD","IE0009355771.USD","IE0002270589.USD","SG9999002232.USD","LU0661504455.SGD","LU0211327993.USD","BK4082","ABT","LU0310799852.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbvie.com","stockEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":-0.0144},{"period":"3month","weight":0.1689},{"period":"6month","weight":0.1498},{"period":"1year","weight":0.1325},{"period":"ytd","weight":0.2842}],"compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.0205},{"period":"3month","weight":0.0935},{"period":"6month","weight":0.1995},{"period":"1year","weight":0.1721},{"period":"ytd","weight":0.16}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"艾伯维公司注册成立于2012年4月10日，是一家全球性的、以研究为基础的生物制药公司。Abbvie公司从事开发和销售先进的疗法，来解决一些世界上最复杂和严重的疾病。Abbvie公司的产品主要集中在慢性自身免疫性疾病领域，包括类风湿性关节炎，牛皮癣和克罗恩病，银屑病和克罗恩病;低睾酮，HIV，子宫内膜异位症;甲状腺疾病;帕金森病;和并发症的慢性肾脏疾病和囊性纤维化相关的或其他健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.384615,"avgChangeRate":-0.018856},{"month":2,"riseRate":0.846154,"avgChangeRate":0.038959},{"month":3,"riseRate":0.769231,"avgChangeRate":0.006022},{"month":4,"riseRate":0.615385,"avgChangeRate":0.009221},{"month":5,"riseRate":0.615385,"avgChangeRate":0.002163},{"month":6,"riseRate":0.461538,"avgChangeRate":0.008788},{"month":7,"riseRate":0.538462,"avgChangeRate":0.01232},{"month":8,"riseRate":0.538462,"avgChangeRate":0.007409},{"month":9,"riseRate":0.538462,"avgChangeRate":0.014941},{"month":10,"riseRate":0.615385,"avgChangeRate":0.010814},{"month":11,"riseRate":0.75,"avgChangeRate":0.065469},{"month":12,"riseRate":0.666667,"avgChangeRate":0.027572}],"exchange":"NYSE","name":"艾伯维公司","nameEN":"AbbVie"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾伯维公司,ABBV,艾伯维公司股票,艾伯维公司股票老虎,艾伯维公司股票老虎国际,艾伯维公司行情,艾伯维公司股票行情,艾伯维公司股价,艾伯维公司股市,艾伯维公司股票价格,艾伯维公司股票交易,艾伯维公司股票购买,艾伯维公司股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾伯维公司(ABBV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾伯维公司(ABBV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}